Mylan, the embattled manufacturer of the lifesaving EpiPen, and CEO Heather Bresch, already under investigation for unscrupulous price hikes and shady business practices, could also find themselves facing a federal False Claims Act lawsuit before long. Three members of the Senate Judiciary Committee sent a letter to U.S. Attorney General Loretta Lynch Wednesday asking the Justice Department to investigate whether Mylan illegally wrongfully classified the EpiPen under the Medicaid Drug Rebate Program, which would allow it to repay a lower percentage of its sales to states in the form of rebates. Chairman Chuck Grassley, R-IA, and Sens. Richard Blumenthal, D-CT, and Amy Klobuchar, ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.